DERMAPHARM HLDG INH O.N./ DE000A2GS5D8 /
| 2024-11-15 9:49:35 PM | Chg. +1.00 | Volume | Bid9:58:00 PM | Ask9:58:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 34.75EUR | +2.96% | 16,766 Turnover: 575,702.50 |
34.60Bid Size: 500 | 34.90Ask Size: 90 | 1.85 bill.EUR | 2.57% | 29.57 |
Assets
|
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 132.6000 | 199.6000 | 222.3000 | 225.7000 | 330.7700 | ||||||
| Intangible Assets | 293 | 297.3000 | 294.8000 | 305 | 544.8600 | ||||||
| Long-Term Investments | - | - | - | - | 23.6000 | ||||||
| Fixed Assets | - | - | - | 878.9000 | 1,530.1700 | ||||||
| Inventories | 175.6000 | 205.7000 | 243.6000 | 255.7000 | 320.7500 | ||||||
| Accounts Receivable | - | - | - | 96.7000 | 90.9300 | ||||||
| Cash and Cash Equivalents | 115 | 120.3000 | 161.4000 | 151 | 158.7200 | ||||||
| Current Assets | 352.9000 | 400.1000 | 519.2000 | 533.9000 | 630.4900 | ||||||
| Total Assets | 1,044.9000 | 1,224.4000 | 1,407 | 1,412.8000 | 2,160.6700 | ||||||
Liabilities
|
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 35.4000 | 50.4000 | 52.1000 | 56.1000 | 86.6400 | ||||||
| Long-term debt | 562 | 581.1000 | 574.7000 | 511.6000 | 963.9500 | ||||||
| Liabilities to Banks | 580.4000 | 607.1000 | 581.1000 | - | - | ||||||
| Provisions | 49.1000 | 62.6000 | 103.6000 | 164.7000 | 256.9000 | ||||||
| Liabilities | 760.4000 | 899.8000 | 907.1000 | 880.4000 | 1,615.5100 | ||||||
| Share Capital | 53.8400 | 53.8400 | 53.8400 | - | - | ||||||
| Total Equity | 284.5000 | 324.6000 | 499.8000 | 531.6000 | 539.2000 | ||||||
| Minority Interests | 5.8000 | 2.6000 | 2.5000 | .9000 | 5.8400 | ||||||
| Total liabilities equity | 1,044.9000 | 1,224.4000 | 1,407 | 1,412.8000 | 2,160.6700 | ||||||
Income Statement
|
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 701 | 793.8000 | 942.9000 | 1,024.8000 | 1,135.3500 | ||||||
| Depreciation (total) | 50.1000 | 49.2000 | 55.6000 | 101.2000 | 104.5800 | ||||||
| Operating Result | 119.5000 | 136.9000 | 298.5000 | 243.7000 | 182.8900 | ||||||
| Interest Income | -8.4000 | -10 | -5.8000 | -13.8000 | -69.7400 | ||||||
| Income Before Taxes | 110.1000 | 125.3000 | 293 | - | - | ||||||
| Income Taxes | 32.3000 | 39.4000 | 84.1000 | 134.2000 | 45.4600 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | -1.7000 | 1.8300 | ||||||
| Net Income | 77.8000 | 85.9000 | 208.9000 | 132.6000 | 58.1100 | ||||||
Per Share
Cash Flow
|
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 100.6000 | 131.1000 | 250.4000 | 288.5000 | 219.4200 | ||||||
| Cash Flow from Investing Activities | -382.2000 | -105.9000 | -129.3000 | -99 | -415.4300 | ||||||
| Cash Flow from Financing | 184 | -14.1000 | -81 | -199.8000 | 204.5300 | ||||||
| Decrease / Increase in Cash | -97.6000 | 11.1000 | 40 | - | - | ||||||
| Employees | 1,853 | 2,311 | 2,373 | 2,563 | 3,497 | ||||||
